Rocket One Inc. (HOTH) Form 10-Q — Aug 14, 2026
Rocket One Inc. (formerly Hoth Therapeutics, now trading as RKTO) reported zero revenue and a six-month net loss of $6,527,116 for the period ended June 30, 2026, widening from $5,675,312 a year earlier, with Q2 losses growing to $3,834,651 from $2,199,476. The company held $7,891,911 in cash, which management says funds at least 12 months of operations, but the financial statements carry going-concern language stating the company's continuation depends on its ability to raise additional capital; the accumulated deficit reached $79,406,459.
Key figures
- Revenue
- 0
- Total Assets
- 9584874
- Cash Position
- 7891911
- Shares Outstanding
- 24897581
- G And AExpense H1
- 3009000
- R And DExpense H1
- 3474000
- Working Capital
- 7197187
- G And AIncrease Q2
- 62.0%
- Accumulated Deficit
- 79406459
- Atm Remaining Capacity
- 5257000
- Placeve SAFE investment
- 250000
- Skystage asset purchase
- 210000
- H1 2026 atm net proceeds
- 5847063
- Net Cash Used In Operating H1
- 6019382
- Atm Shares Sold Since Nov2024
- 9825684
- Potential Milestone Payments
- 29000000
- Shares Outstanding Dec31 2025
- 15514312
- Shares Outstanding Jun30 2026
- 23184634
- Atm Gross Proceeds Since Nov2024
- 13560000
- Share Count Growth Since Year End
- approximately 60%
- April2026 private placement net
- 1611880
- H1 2026 atm avg price per share
- 1.4
- April2026 warrant exercise price
- 0.85
- April2026 private placement gross
- 2000000
- April2026 placement price per share
- 0.7
- Subsequent atm net proceeds jul1 aug13
- 1938593
Price after filing
Close on the filing date to close N calendar days later (from $0.76). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.